Literature DB >> 15015009

Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.

Bart Van Everbroeck1, Itte Dobbeleir, Michele De Waele, Peter De Deyn, Jean-Jacques Martin, Patrick Cras.   

Abstract

Our objective was to describe the clinical signs of 'possible' Creutzfeldt-Jakob disease (CJD) and to investigate whether current diagnostic criteria can accurately differentiate between different forms of dementia. We studied clinical data of 'definite' CJD, Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and vascular dementia (VD) patients. Two subgroups were used: the first consisted of patients with clinical signs compatible with 'possible' CJD but in whom another final diagnosis was made and a second group with a typical evolution of the respective dementia. More focal neurological deficits were observed in AD, DLB or VD patients initially classified as 'possible' CJD than in typical patients. A typical electroencephalogram showing periodic sharp wave complexes was observed in 26 (50%) CJD and 6% of other dementia patients. The 14-3-3 protein was detected in all CJD and 8% of other dementia patients. In patients with rapidly progressive dementia and focal neurological signs, CJD should be considered. When faced with the triad: dementia, myoclonus, and initial memory problems AD should be considered if the disease duration is longer than 1 year. The diagnosis of DLB is suggested, if Parkinsonism or fluctuations are present, whereas a focal onset and compatible brain imaging can indicate VD. Findings suggestive of CJD on EEG, brain imaging, and CSF do not exclude other dementias but make them very unlikely. These observations cannot only assist in the differential diagnosis of CJD but also with the identification of AD, DLB or VD patients with atypical clinical history.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15015009     DOI: 10.1007/s00415-004-0311-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK.

Authors:  S A Cooper; K L Murray; C A Heath; R G Will; R S G Knight
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-07-11       Impact factor: 10.154

2.  Pellagra encephalopathy as a differential diagnosis for Creutzfeldt-Jakob disease.

Authors:  Istvan Kapas; Katalin Majtenyi; Klara Törö; Eva Keller; Till Voigtländer; Gabor G Kovacs
Journal:  Metab Brain Dis       Date:  2012-04-27       Impact factor: 3.584

3.  Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.

Authors:  Numthip Chitravas; Richard S Jung; Diane M Kofskey; Janis E Blevins; Pierluigi Gambetti; R John Leigh; Mark L Cohen
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

4.  Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease.

Authors:  Moeko Noguchi-Shinohara; Tsuyoshi Hamaguchi; Ichiro Nozaki; Kenji Sakai; Masahito Yamada
Journal:  J Neurol       Date:  2011-03-01       Impact factor: 4.849

5.  Detection of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease Patients Using a New Automated Capillary Western Assay.

Authors:  A Fourier; A Dorey; A Perret-Liaudet; I Quadrio
Journal:  Mol Neurobiol       Date:  2017-05-16       Impact factor: 5.590

6.  Differential diagnosis of Jakob-Creutzfeldt disease.

Authors:  Ross W Paterson; Charles C Torres-Chae; Amy L Kuo; Tim Ando; Elizabeth A Nguyen; Katherine Wong; Stephen J DeArmond; Aissa Haman; Paul Garcia; David Y Johnson; Bruce L Miller; Michael D Geschwind
Journal:  Arch Neurol       Date:  2012-12

7.  Structural signature of sporadic Creutzfeldt-Jakob disease.

Authors:  J Navid; G S Day; J Strain; R J Perrin; R C Bucelli; A Dincer; J K Wisch; D Soleimani-Meigooni; J C Morris; T L S Benzinger; B M Ances
Journal:  Eur J Neurol       Date:  2019-03-25       Impact factor: 6.089

Review 8.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

Review 9.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

10.  Classification of sporadic Creutzfeldt-Jakob disease based on clinical and neuropathological characteristics.

Authors:  José Cortiñas Abrahantes; Marc Aerts; Bart van Everbroeck; Claude Saegerman; Dirk Berkvens; Helena Geys; Koen Mintiens; Stefan Roels; Patrick Cras
Journal:  Eur J Epidemiol       Date:  2007-06-21       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.